Effects of anti-TNF-alfa in experimental diversion colitis

Buanaim, Ronaldo Parisi; Pereira, José Aires; Campos, Fabio Guilherme; Kotze, Paulo Gustavo; Goto, Eduardo Felipe Kim; Mendonça, Roberta Laís Silva; Kanno, Danilo Toshio; Martinez, Carlos Augusto Real.
Acta cir. bras. ; 34(10): e201901004, 2019. ilus, graf
Artículo en Inglés | VETINDEX | ID: vti-24044

Documentos relacionados

  1. IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience.
  2. EXPRESSION OF E-CADHERIN AND CLAUDIN-3 IN THE COLONIC EPITHELIUM AFTER THE INFLIXIMAB THERAPY: EXPERIMENTAL MODEL OF DISUSE COLITIS.
  3. Systematic Review: Efficacy and Safety of Accelerated Induction Regimes in Infliximab Rescue Therapy for Hospitalized Patients with Acute Severe Colitis.
  4. Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
  5. Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis.
  6. Infliximab rescue therapy in a case of severe granulomatous colitis associated with rituximab use.
  7. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
  8. Immune Checkpoint Inhibitors-Induced Colitis.
  9. Expressão de e-caderina e claudina-3 no epitélio cólico após terapia com infliximabe: modelo experimental de colite de exclusão
  10. Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.